Chapter 360 - 237: Sensation! The Fermentation of Public Opinion (3)

Chapter 360: Chapter 237: Sensation! The Fermentation of Public Opinion (3)

However, Jin Yihong, having just gone through so much trouble to reclaim her equity, was not about to dilute her shares again.

These investment firms then approached Wu Ting, hoping to invest in his company, but he flatly refused.

All of Wu Ting’s research projects were progressing steadily. With a constant stream of grants and funding, plus support from the Pfizer settlement fund, he had absolutely no need for outside capital.

Moreover, contracts had been signed and a market strategy was in place for all of Wu’s Pharmaceutical Company’s products. Going forward, its product line and market position would only grow larger and more stable.

Wu Ting had already amassed his initial capital. All he had to do now was continue to monetize the results of his research and development.

As for Wu’s Pharmaceutical Company, the parent company, Wu Ting had no intention of taking it public. He would keep everything under his own control.

After all, to Wu Ting, his true profession was still that of a doctor. The company, the money—they were all just byproducts on his journey to the pinnacle of medicine.

「The next morning.」

Wu Ting, Jin Yihong, and the others headed back to Xiao City, leaving Deng Feifei behind in Qinghe City to handle the specific details, negotiations, and contract signings for the upcoming business partnerships.

Upon arriving at Xiaoshan International Airport, Jin Yihong offered Wu Ting a few more words of gratitude and advice before they parted ways.

"Dr. Wu, I really can’t thank you enough for everything. The company’s comeback is all thanks to you."

"Once I’m back, I’ll make the necessary arrangements to ensure the company fully supports the plans you and Feifei have made."

"And not just as the Chairwoman of Jin Pharmaceutical Group, but as a mother, I want to thank you again."

"From now on, Feifei will be staying at Wu’s Pharmaceutical Company to work alongside you. Please look after her. I’m leaving her in your hands."

Jin Yihong was completely at ease leaving Deng Feifei at Wu’s Pharmaceutical Company to partner with Wu Ting, as she knew he was a man of both exceptional talent and moral character.

Ever since she started working with Wu Ting, Deng Feifei’s performance in the business world had been steadily improving. Jin Yihong intended for her to take charge at Wu’s Pharmaceutical Company. With Wu Ting on the inside and Feifei on the outside, they could jointly build a pharmaceutical giant even larger than Jin Pharmaceutical Group!

"President Jin, you can rest assured. I’ll take good care of Deng Feifei."

’Wu Ting was also quite fond of Deng Feifei. She was talented and strong-willed, not to mention beautiful, with a great figure, fair, smooth skin, and fine, soft hair. Her features were delicate, her lips soft, her teeth pearly white, and her earlobes were as exquisite as crystalline jade.’

Wu Ting and Zhang Heng first returned to City First Hospital.

Jia Jun planned to visit Lou Musaang in the next few days and would return to the liver tumor lab after that.

...

...

While Wu Ting and Zhang Heng were back at City First Hospital arranging their work, the stock price of Jin Pharmaceutical Group began to soar on the market.

For the next few days, it continued to hit new highs every single day.

By the time Deng Feifei returned after signing a mountain of orders and arranged for the Jin Pharmaceutical Group’s factories to begin production, the company’s stock price had reached a new peak.

Jin Pharmaceutical Group’s market capitalization reached 1.5 times its previous peak, soaring directly to 225 billion!

This was a staggering figure. Correspondingly, the personal net worth of both Jin Yihong and Wu Ting skyrocketed.

With her 51% stake, Jin Yihong’s net worth reached 114.7 billion!

As the second-largest shareholder, Wu Ting’s 15% stake was now worth 33.75 billion!

At the current stock price, Jin Yihong had broken into the top thirty of the Jin Country Forbes Rich List for the first time!

After calculating Wu Ting’s net worth, Deng Feifei decided it was time to add more fuel to the fire of his growing fame.

As a young elite in the business world herself, Deng Feifei’s goal had once been to make the Forbes 30 Under 30 list.

Unlike the Rich List, the Forbes 30 Under 30 list has a selection process that requires individuals to fill out an application and nominate themselves.

In 2011, the Southern Country edition of Forbes magazine launched its "30 Under 30" list.

The list aims to recognize young trailblazers under the age of 30 who made outstanding contributions in various fields during the previous year.

The selection criteria for the list include the disruptive impact they’ve had on their field, their entrepreneurial mindset and achievements, and their potential to change their industry.

This list is different from the Rich List; you can’t get on it just by doing nothing and inheriting assets. Money alone just makes you nouveau riche, not an "elite" as defined by Forbes, because your capital hasn’t been connected to real-world impact.

To make the Forbes 30 Under 30 list, two basic qualifications are required.

First, an outstanding career.

The list is divided into 20 categories, with 30 representatives chosen for each.

These categories include: Healthcare, Art & Pop Culture, Consumer Technology, Retail & E-commerce, Enterprise Technology, Hollywood & Entertainment, Education, Gaming, Law & Policy, Finance, Venture Capital, Sports, Social Impact, Science, Energy, Manufacturing & Industry, Marketing & Advertising, Celebrities, Media, and Big Money.

Second, you need to have your own unique influence.

For example, if you play soccer, you need to have the skill of a Messi; if you don’t have the skill, you at least need his presence. If you’re an actor, you need the talent of a Marlon Brando; if you don’t have the talent, you at least need his fame. If you’re an entrepreneur, you need a product like Zuckerberg, whether it’s "borrowed" or original. If you’re in software, you need the guts of an Evan Spiegel, the kind of audacity that makes you refuse to sell out to Zuckerberg.

Without a doubt, given Wu Ting’s current scientific and business accomplishments, he absolutely met every requirement.

Furthermore, with his good looks and charisma, Wu Ting was the very image of a top-tier, idol-like elite.

Deng Feifei’s goal in doing this was to leverage the influence and prestige of Forbes to make Wu Ting—the Chairman and Chief Scientist of Wu’s Pharmaceutical Company—and his elite image even more widely known.

This would be incredibly beneficial for both Wu Ting’s future career and the prospects of Wu’s Pharmaceutical Company, with absolutely no downside.

With her characteristic efficiency, Deng Feifei filled out all of Wu Ting’s information and submitted his application for the Jin Country Forbes "30 Under 30" list!